Growth Metrics

Baxter International (BAX) Capital Expenditures (2016 - 2025)

Baxter International (BAX) has disclosed Capital Expenditures for 17 consecutive years, with $140.0 million as the latest value for Q4 2025.

  • Quarterly Capital Expenditures rose 6.06% to $140.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $513.0 million through Dec 2025, up 15.02% year-over-year, with the annual reading at $513.0 million for FY2025, 15.02% up from the prior year.
  • Capital Expenditures for Q4 2025 was $140.0 million at Baxter International, up from $111.0 million in the prior quarter.
  • The five-year high for Capital Expenditures was $183.0 million in Q4 2021, with the low at -$61.0 million in Q4 2022.
  • Average Capital Expenditures over 5 years is $123.0 million, with a median of $138.5 million recorded in 2022.
  • The sharpest move saw Capital Expenditures tumbled 133.33% in 2022, then skyrocketed 1016.67% in 2024.
  • Over 5 years, Capital Expenditures stood at $183.0 million in 2021, then tumbled by 133.33% to -$61.0 million in 2022, then surged by 250.82% to $92.0 million in 2023, then skyrocketed by 43.48% to $132.0 million in 2024, then grew by 6.06% to $140.0 million in 2025.
  • According to Business Quant data, Capital Expenditures over the past three periods came in at $140.0 million, $111.0 million, and $140.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.